MiNK Therapeutics, Inc. - Stock (INKT)

CUSIP: 603693102

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Stock
Total 13F shares
846,638
Share change
-52,821
Total reported value
$632,308
Price per share
$0.75
Number of holders
25
Value change
-$46,624
Number of buys
7
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q3 2024

As of 30 Sep 2024, MiNK Therapeutics, Inc. - Stock (INKT) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 846,638 shares. The largest 10 holders included VANGUARD GROUP INC, Longbow Finance SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., HighTower Advisors, LLC, STATE STREET CORP, CAPTRUST FINANCIAL ADVISORS, TWO SIGMA SECURITIES, LLC, and NORTHERN TRUST CORP. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.